Clinical, hematologic, and immunologic effects of interleukin-10 in humans

Journal of Clinical Immunology

Volumn 16, Issue 5, 1996, Pages 291-303

  Fuchs, Amy C ^a   Granowitz, Eric V ^a   Shapiro, Leland ^a   Vannier, Edouard ^a   Lonnemann, Gerhard ^a   Angel, Jonathan B ^a   Kennedy, Jeffrey S ^a   Rabson, Arthur R ^a   Radwanski, Elaine ^b   Affrime, Melton B ^b   Cutler, David L ^b   Grint, Paul C ^b   Dinarello, Charles A ^a,c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

cytokines; interferon ; interleukin 6; interleukin 8; Th1 and Th2 lymphocytes

Indexed keywords

CD2 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; RECOMBINANT INTERLEUKIN 10;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTOSIS; MALE; NEUTROPHIL; NORMAL HUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; ANTIBODY FORMATION; BLOOD CELL COUNT; DOUBLE-BLIND METHOD; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; MALE; SUPEROXIDES;

EID: 10144229329     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01541395     Document Type: Article

References (29)

1. Yssel H, De Waal Malefyt R, Roncarolo M, Abrams JS, Lahesmaa R, Spits H, De Vries JE: IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J Immunol 149:2378-2384, 1992
2. Viera P, De Waal Malefyt R, Dang MN, Johnson KE, Kastelein R, Fiorentino DF, De Vries JE, Roncarlo MG, Mosmann TR, Moore KW: Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: Homology to Epstein-Barr virus open reading frame BCRFI. Proc Natl Acad Sci USA 88:1172-1176, 1991
3. Taga K, Tosato G: IL-10 inhibits T cell proliferation and IL-2 production. J Immunol 148:1143-1148, 1992
4. Dinarello CA: Biologic basis for interleukin-1 in disease. Blood 87:2095-2147, 1996
5. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-1220, 1991
6. Cassatella MA, Meda L, Bonora S, Ceska M, Constantin G: Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1β in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 178:2207-2211, 1993
7. Schindler R, Dinarello CA: Ultrafiltration to remove endotoxins and other cytokine-inducing materials from tissue culture media and parenteral fluids. Biotechniques 8:408-413, 1990
8. Chernoff AE, Granowitz EV, Shapiro L, Vannier E, Lonnemann G, Angel JB, Kennedy JS, Rabson AR, Wolff SM, Dinarello CA: A randomized, controlled trial of interleukin-10 in humans: Inhibition of inflammatory cytokines and immune responses. J Immunol 154:5492-5499, 1995
9. Klempner MS, Dinarello CA, Henderson WR, Gallin JI: Stimulation of neutrophil oxygen-dependent metabolism by human leukocyte pyrogen. J Clin Invest 64:996-1002, 1979
10. Cannon J, Van der Meer J, DK, Endres S, Lonnemann G, Burke J, Dinarello C: Interleukin-1β in human plasma: Optimization of blood collection, plasma extraction, and radioimmunoassay methods. Lymphokine Res 7:457-467, 1988
11. van der Meer JWM, Endres S, Lonnemann G, Cannon JG, Ikejima T, Okusawa S, Gelfand JA, Dinarello CA: Concentrations of immunoreactive human tumor necrosis factor-α produced by human mononuclear cells in vitro. J Leukoc Biol 43:216-223, 1988
12. Schindler R, Mancilla J, Endres S, Ghorbani R, Clark SC, Dinarello CA: Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 75:40-47, 1990
13. Porat R, Poutsiaka DD, Miller LC, Granowitz EV, Dinarello CA: Interleukin-1 (IL-1) receptor blockade reduces endotoxin and Borrelia burgdorferi-stimulated IL-8 synthesis in human mononuclear cells. FASEB J 6:2482-2486, 1992
14. Shapiro L, Clark BD, Orencole SF, Poutsiaka DD, Granowitz EV, Dinarello CA: Detection of tumor necrosis factor soluble receptor p55 in blood samples from healthy and endotoxemic humans. J Infect Dis 167:1344-1350, 1993
15. Poutsiaka DD, Clark BD, Vannier E, Dinarello CA: Production of interleukin-1 receptor antagonist and interleukin-1β by peripheral blood mononuclear cells is differentially regulated. Blood 78: 1275-1281, 1991
16. Bocci V: Interleukins: Clinical pharmacokinetics and practical implications. Clin Pharmacokinet 21:274-284, 1991
17. Roussel F, Garcia E, Defrance T, Peronne C, Vezzio N, Hsu D, Kastelein R, Moore KW, Banchereau J: Interleukin 10 is a potent growth and differentiation factor for activated human B lympho-cytes. Proc Natl Acad Sci USA 89:1890-1893, 1992
18. Zielen S, Bauscher P, Hofmann D, Meuer SC: Interleukin 10 and immune restoration in common variable immunodeficiency [letter]. Lancet 342:750-751, 1993
19. Mulligan MS, Jones ML, Vaporciyan AA, Howard MC, Ward PA: Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. J Immunol 151:5666-5674, 1993
20. Helle M, Brakenhoff JP, De GER and Aarden LA: Interleukin 6 is involved in inlerleukin 1-induced activities. Eur J Immunol 18: 957-959, 1988
21. Hirano T, Taga T, Nakano N, Yasukawa K, Kashiwamura S, Shimizu K, Nakajimu K, Pyun KH, Kishimoto T: Purification to homogeneity and characterization of human B cell differentiation factor (BCDF or BSFp-2). Proc Natl Acad Sci USA 82:5490-5494, 1985
22. Gauldie J, Richards C, Harnish D, Lansdorp P, Baumann H: Interferon β2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 84:7251-7255, 1987
23. Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, Tang B, Tanabe O, Tanaka H, Kuramoto A, Kishimoto T: Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332:83-85, 1988
24. Nordan RP, Potter M: A macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro. Science 233:566-569, 1986
25. Houssiau FA, Devogelaer J-P, Van Damme J, De Deuxchaisnes CN, Van Snick J: Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arth Rheum 31:784-788, 1988
26. Hirano T, Taga T, Kiyoshi Y, Nakajima K, Nakano N, Takatsuki F, Shimizu M, Murashima A, Tsunasawa S, Sakiyama F, Kishimoto T: Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production. Proc Natl Acad Sci USA 84:228-231, 1987
27. Yoshizaki K, Matsuda T, Nishimoto N, Kuritani T, Taeho L, Aozasa K, Nakahata T, Kawai H, Tagoh H, Komori T, Kishimoto S, Hirano T, Kishimoto T: Pathological significance of interleukin 6 (IL-6/BSF2) in Castelmans' disease. Blood 74:1360-1367, 1989
28. Beck JT, Hsu S, Wijdenes J, Bataille R, Klein B, Vesole D, Hayden K, Jagannath S, Barlogie B: Brief report: Alleviation of systemic manifestations of Castelman's disease by monoclonal anti-interleukin-6 antibody. N Engl J Med 330:602-605, 1994
29. Elias JA, Schreiber AD, Gustilo K, Chien P, Rossman MD, Lammie PJ, Daniele RP: Differential interleukin l elaboration by unfractionated and density fractionated human alveolar macrophages and blood monocytes: Relationship to cell maturity. J Immunol 135:3198-3204, 1985